Who Owns IQVIA?
IQVIA is the master brand of IQVIA Holdings Inc. (NYSE: IQV), a healthcare intelligence and contract research company headquartered in Durham, North Carolina. The brand covers clinical trial services, healthcare data analytics, and commercial solutions for pharmaceutical and life sciences clients, a business generating $16.3 billion in fiscal year 2025.
Parent Company
Founded
2016
Status
Publicly Traded
Headquarters
GlobalOfficial Website
Who Owns IQVIA?
- Parent Company: IQVIA Holdings Inc.
- Ownership Type: Brand division
- Company Type: Publicly Traded
- Stock Ticker: NYSE: IQV
| Brand | Parent Company | Ownership Type |
|---|---|---|
| IQVIA | IQVIA Holdings Inc. | Brand division |
Where to Buy
Disclosure: We may earn commission from purchases
IQVIA on AmazonAdvertisement
History of IQVIA
- Founded: 2016
- Founders: Merger of Quintiles (1982) and IMS Health (1954)
The IQVIA name is young but its components are industry institutions. Quintiles, founded by Dennis Gillings in Chapel Hill in 1982, essentially invented the contract research organization and grew into the world's largest. IMS Health, founded in 1954, built the dominant pharmaceutical sales and prescribing data business.
The 2016 merger united the trials and data sides under one company, and the IQVIA name replaced the transitional Quintiles IMS branding in 2017.
The brand's modern identity is the combination it claims: clinical research scale plus proprietary health data covering billions of records, packaged as IQVIA Connected Intelligence and Healthcare-grade AI. Through 2025 the brand navigated a biotech funding downturn and emerged with near double-digit revenue growth.
Advertisement
About IQVIA Holdings Inc.
What does IQVIA own?
The company owns its clinical research operations, healthcare data and analytics platforms, the IQVIA Connected Intelligence platform, and commercial services businesses.
Is IQVIA publicly traded?
Yes. It trades on the New York Stock Exchange under ticker IQV and is an S&P 500 component.
When was IQVIA founded?
The company formed in 2016 through the merger of Quintiles (founded 1982) and IMS Health (founded 1954).
What does IQVIA do?
It runs outsourced clinical trials for pharmaceutical companies as the world's largest contract research organization, and provides healthcare data, analytics, and commercial services to life sciences and healthcare clients.
Advertisement
Who owns IQVIA?
Public shareholders own the company through the NYSE listing, with institutional investors dominant.
What is the difference between R&DS and TAS?
R&DS is the clinical trials business; TAS is the data, analytics, and technology business. Together they cover the drug development and commercialization lifecycle.
- Founded: 2016
- Headquarters: Durham, North Carolina, USA
- Company Type: Publicly Traded
- Stock: NYSE: IQV
- Revenue: $16.3 billion (FY2025)
- Employees: Approximately 90,000
Where Is IQVIA Made / Based?
- Headquarters: Durham, North Carolina, USA
IQVIA Categories & Tags
IQVIA Recalls & Controversies
Health data privacy: The brand's core asset is patient data, and its collection, de-identification, and commercial use draw periodic scrutiny as the largest player in an industry-wide privacy debate.
Clinical trial conduct: As the largest CRO it faces routine GCP inspections and findings across global regulators, resolved through corrective actions as standard industry practice.
Advertisement
Market concentration: Its data position attracts periodic antitrust questions about health information concentration, with no major enforcement on record.
IQVIA Ownership: Pros & Cons
Advantages
- +Dual moat: largest CRO scale plus unique health data assets
- +Contract-backed recurring revenue with trial visibility
- +Proprietary datasets are expensive for competitors to replicate
- +AI investments strengthen the integrated commercial pitch
Considerations
- -Biotech funding cycles drive booking volatility
- -Health data regulation could constrain the data business
- -Pharma consolidation shrinks the customer base to fewer, larger buyers
- -Scale limits incremental share gains
Frequently Asked Questions About IQVIA
Advertisement
Sources & Further Reading
Competitors to IQVIA
No direct competitors found in the same category. This could be because IQVIAoperates in a unique market segment or we're still building our competitor database.
Advertisement
Independent Alternatives to IQVIA
Looking for brands with different ownership structures? These similar brands are not owned by IQVIA Holdings Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsBand-Aid
Owned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
wound-careadhesive-bandagefirst-aid
Privately Owned
Band-Aid is privately owned, unlike IQVIA which is under a publicly traded parent company.
Healthcare PharmaceuticalsBenadryl
Owned by Kenvue
American brand of antihistamine medication used to treat allergies, itching, and cold symptoms, manufactured and marketed by Johnson & Johnson.
antihistamineallergy-reliefcold-medicine
Privately Owned
Benadryl is privately owned, unlike IQVIA which is under a publicly traded parent company.
Healthcare PharmaceuticalsBoots
Owned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
pharmacyhealth-beautyuk-retail
Privately Owned
Boots is privately owned, unlike IQVIA which is under a publicly traded parent company.
Healthcare PharmaceuticalsDuane Reade
Owned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
pharmacydrugstorenew-york
Privately Owned
Duane Reade is privately owned, unlike IQVIA which is under a publicly traded parent company.
Healthcare PharmaceuticalsMotrin
Owned by Kenvue
American brand of ibuprofen pain relief medication owned by Kenvue, the consumer health spinoff from Johnson & Johnson, which is being acquired by Kimberly-Clark in a $40 billion deal announced in November 2025.
pain-reliefibuprofenanti-inflammatory
Privately Owned
Motrin is privately owned, unlike IQVIA which is under a publicly traded parent company.
Healthcare PharmaceuticalsNeosporin
Owned by Kenvue
American brand of over-the-counter first aid antibiotic ointment containing bacitracin, neomycin, and polymyxin B. Owned by Kenvue (NYSE: KVUE) since the August 2023 spin-off from Johnson & Johnson.
antibiotic-ointmentwound-caretopical
Privately Owned
Neosporin is privately owned, unlike IQVIA which is under a publicly traded parent company.
IQVIA Holdings Inc. Stock Information
Advertisement
Jobs at IQVIA Holdings Inc.
Latest News About IQVIA
Advertisement
Related Articles About IQVIA
View more articles
News & Updates
Monthly IPO Roundup: November 2026 -- October's Biggest Listings
October 2026 IPOs: Jio Platforms set India's all-time record at $3.2B and surged 27%, GCash owner Mynt raised a Philippine-record P60.9B, Anthropic filed publicly for a possible mid-November debut, and U.S. listings were a biotech grab bag. Full recap.
Who Brands StaffNov 6, 2026
Ipo RoundupIpoStock Market
News & Updates
Monthly M&A Roundup: October 2026 Brand Ownership Changes
October 2026's biggest deals: Paramount Skydance closed its $110B Warner Bros. Discovery takeover, Salesforce signed Braze for $5.66B, Proofpoint bought Varonis for $6.3B, the Weston family agreed to buy Boots for $8.9B, and Viatris added Pacira for $1.65B. Full breakdown.
Who Brands StaffNov 6, 2026
M And A RoundupAcquisitionsNews
Rivalry
Duracell vs Energizer: The Battery Brand Rivalry
Duracell is Berkshire Hathaway-owned (25-30% US share). Energizer is publicly traded (NYSE: ENR) with Rayovac. Together they control ~85% of branded US batteries, but Amazon Basics has 27.1% online. Explore our database.
Who Brands StaffOct 23, 2026
DuracellEnergizerRivalry
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandrsv-vaccine
Abrysvo
Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.
Brand in Healthcare & Pharmaceuticals
vaccinesmaternal-immunization
Branddermatology
Accutane
Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.
Brand in Healthcare & Pharmaceuticals
acne-treatmentprescription